L’Oreal has reached a settlement with four women who sued the US branch of the French cosmetics giant claiming that a hair straightening product caused their cancer.
Danielle Ward Mason, an attorney for the plaintiffs, announced the agreement reached on Monday, November 16, but did not disclose the amount of the settlement, which came as the case was going to trial in Chicago.
The suit is one of a number filed against the company and other manufacturers of chemical hair relaxer products, which are predominantly used by Black women. A 2022 study published in the Journal of the National Cancer Institute pointed to a potential link between usage of chemical hair straightening products and uterine cancer.
In a statement, a spokesperson for L’Oréal USA said "we stand by the safety" of the company’s products.
"Our highest priority is the health and wellbeing of all our consumers," the spokesperson said. "Our products are subject to a rigorous scientific evaluation of their safety by experts who also ensure that we strictly follow all regulations in every market in which we operate."
Mason, the lawyer for the plaintiffs, said the four women "trusted the defendants’ assurances that these hair relaxer products were safe, and they have paid a heavy price for that trust."
"From the very beginning, our goal has been to make sure women harmed by these products are heard and compensated, and that the companies that put them on the market are held accountable," Mason said.
"This is an important step, but our work is far from over," she said. "Every woman harmed by these products deserves justice, and the next generation deserves real protections and honest warnings about their safety."
























